2017-03-07,Aerie Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Business Update
2017-03-05,4 Small-Cap Biotech Stars
2017-03-03,4 Small-Cap Biotech Stars
2017-03-02,Aerie Pharmaceuticals To Present At Three Investor Conferences In March
2017-03-01,Aerie Pharmaceuticals Announces Resubmission Of NDA For RhopressaTM (netarsudil Ophthalmic Solution) 0.02%
2017-02-27,Aerie Pharmaceuticals To Announce Fourth Quarter And Year End 2016 Financial Results And Host Conference Call On Tuesday, March 7, 2017
2017-02-15,Aerie Pharmaceuticals To Present At The RBC Capital Markets 2017 Global Healthcare Conference
2017-02-13,Noteworthy Monday Option Activity: AERI, NHTC, SUPN
2017-02-06,Aerie Pharmaceuticals Announces Appointment Of Huan Sheng, M.D., Ph.D., As Director Clinical Research And Drug Safety
2017-02-03,Aerie Pharmaceuticals Announces Appointment Of Barry Ivin As Site Director Of New Manufacturing Plant In Ireland
2017-01-27,Dearth of Momentum Helps Build 'Wall of Worry'
2017-01-23,Aerie Pharmaceuticals Announces Appointment Of Kristine Erickson, O.D., Ph.D., As Vice President Clinical Research
2017-01-23,Allergan, Apple, Facebook: Doug Kass' Views
2017-01-16,Allergan, Citigroup, Apple: Doug Kass' Views
2017-01-09,Aerie Pharmaceuticals Enters Into Lease Agreement For New Manufacturing Plant In Ireland
2017-01-03,Inotek Pharma Shares Plummet Following Negative Glaucoma Trial Results
2017-01-03,Inotek Pharma Glaucoma Drug Suffers Study Setback at Start of New Year
2016-12-23,Aerie Pharmaceuticals Provides Update On Timing Of NDA Filing For RhopressaTM (netarsudil Ophthalmic Solution) 0.02%
2016-12-22,What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
2016-12-19,Aerie Pharmaceuticals Announces Appointment Of Judith J. Robertson As Chief Commercial Officer
2016-12-19,Apple, Alphabet, Starbucks: Doug Kass' Views
2016-12-07,Aerie Pharmaceuticals Completes Enrollment Of Mercury 2 Phase 3 Registration Trial Of Roclatan™ (netarsudil/latanoprost Ophthalmic Solution) 0.02%/0.005%
2016-12-01,Aerie Pharmaceuticals To Participate In Two Investor Conferences In December
2016-11-28,Home Depot, Lowe's, Best Buy: Doug Kass' Views
2016-11-25,Apple Continues to Underperform; the Market Is Resistant: Best of Kass
2016-11-21,Facebook, Home Depot, Disney: Doug Kass' Views
2016-11-16,4 Stocks You Should Watch Because They're Breaking Out Higher
2016-11-07,Cisco, Allergan, Facebook: Doug Kass' Views
2016-11-03,Aerie Pharmaceuticals To Participate In Three Investor Conferences In November
2016-11-02,Aerie Pharmaceuticals Reports Third Quarter 2016 Financial Results And Provides Business Update
2016-10-27,Aerie Pharmaceuticals Reports Positive Topline Efficacy Results Of Rocket 4 Phase 3 Trial Of RhopressaTM (netarsudil Ophthalmic Solution) 0.02%
2016-10-25,Aerie Pharmaceuticals To Announce Third Quarter 2016 Financial Results And Host Conference Call On Wednesday, November 2, 2016
2016-10-24,Schlumberger, Amazon, Apple: Doug Kass' Views
2016-10-03,J.C.Penney, Wells Fargo, Deutsche Bank: Doug Kass' Views
2016-09-28,Aerie Pharmaceuticals To Host Investor Day On October 5, 2016
2016-09-21,Cloudy Outlook for Aerie Pharma's Glaucoma Drug
2016-09-19,Wells Fargo, Citigroup, Apple: Doug Kass' Views
2016-09-16,Notable Friday Option Activity: AERI, AWH, WATT
2016-09-16,Aerie Pharmaceuticals Raises $125 Million In Public Offerings
2016-09-15,Aerie Pharmaceuticals Announces Public Offering Of Common Stock
2016-09-15,Trending Tickers: AAPL, TMUS, FIT, AERI
2016-09-15,Bought Aerie Earlier? Congratulations
2016-09-15,Why Shares of Aerie Pharmaceuticals (AERI) are Soaring Today
2016-09-14,Aerie Pharmaceuticals Reports Positive Roclatan™ (netarsudil/latanoprost Ophthalmic Solution) 0.02%/0.005% Phase 3 Topline Efficacy Results
2016-09-14,Fear of Being Left Out Is Lifting Indices
2016-09-09,4 Biotechs Set to Provide a Shot in the Arm
2016-09-09,4 Biotechs Set to Provide a Shot in the Arm
2016-09-06,Aerie Pharmaceuticals Submits New Drug Application To U.S. Food And Drug Administration For Rhopressa™ (netarsudil Ophthalmic Solution) 0.02%
2016-08-30,2 Biotechs to Watch Ahead of the Election
2016-08-25,Aerie Pharmaceuticals Stock Sees Short Interest Decline 17%
2016-08-04,Aerie Pharmaceuticals To Present At The Canaccord Genuity Growth Conference
2016-08-03,Aerie Pharmaceuticals Reports Second Quarter 2016 Financial Results And Provides Business Update
2016-07-27,Aerie Pharmaceuticals To Announce Second Quarter 2016 Financial Results And Host Conference Call On Wednesday, August 3, 2016
2016-07-22,Noteworthy Friday Option Activity: AERI, NAV, CBI
2016-07-06,Aerie Pharmaceuticals To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
2016-06-27,First Week of February 2017 Options Trading For Aerie Pharmaceuticals (AERI)
2016-06-16,Aerie Pharmaceuticals Completes Enrollment Of Rocket 4 Phase 3 Clinical Trial Of RhopressaTM (netarsudil Ophthalmic Solution) 0.02%
2016-06-02,Aerie Pharmaceuticals To Participate In Two Investor Conferences In June
2016-05-05,Aerie Pharmaceuticals Completes Enrollment Of Mercury 1 Phase 3 Registration Trial Of RoclatanTM (netarsudil/latanoprost Ophthalmic Solution) 0.02%/0.005%
2016-05-04,Aerie Pharmaceuticals To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference
2016-05-02,Aerie Pharmaceuticals Reports First Quarter 2016 Financial Results And Provides Business Update
2016-04-25,Aerie Pharmaceuticals To Announce First Quarter 2016 Financial Results And Host Conference Call On Monday, May 2, 2016
2016-04-14,Commit To Buy Aerie Pharmaceuticals At $12.50, Earn 38.6% Annualized Using Options
2016-04-05,Aerie Pharmaceuticals To Present At The 15th Annual Needham Healthcare Conference
2016-03-28,Short Interest Moves 18.4% Higher For AERI
2016-03-28,Aerie Pharmaceuticals Initiates Second Phase 3 Registration Trial Of RoclatanTM (netarsudil/latanoprost Ophthalmic Solution) 0.02%/0.005%
2016-03-17,Aerie Pharmaceuticals Reports Update On Positive Safety Results For RhopressaTM QD (netarsudil Ophthalmic Solution) 0.02%
2016-03-09,Aerie Pharmaceuticals Becomes Oversold (AERI)
2016-03-07,Tesla, Amazon and Netflix: Doug Kass' Views
2016-03-03,Noteworthy Thursday Option Activity: AERI, GB, W
2016-03-03,Aerie Pharma Falls on Glaucoma Eye Drop Safety Concerns
2016-03-03,Aerie Pharmaceuticals Announces Availability On Its Website Of Abstracts To Be Presented At The American Glaucoma Society 26th Annual Meeting
2016-03-01,Aerie Pharmaceuticals Reports Year End 2015 Financial Results And Provides Business Update
2016-02-22,Aerie Pharmaceuticals Announces Four New Abstracts To Be Presented At The American Glaucoma Society 26th Annual Meeting Next Week
2016-02-22,Aerie Pharmaceuticals To Announce Fourth Quarter And Year End 2015 Financial Results And Host Conference Call On Tuesday, March 1, 2016
2016-02-22,Amazon, Berkshire Hathaway and Potash: Doug Kass' Views
2016-02-19,What Carl Icahn Is Doing; Biotech Breakout: Best of Kass
2016-02-18,One Reason Why Aerie Pharmaceuticals (AERI) Stock is Soaring Today
2016-02-17,Aerie Pharmaceuticals Reports Positive RhopressaTM QD (netarsudil Ophthalmic Solution) 0.02% 12 Month Interim Safety Results For Rocket 2
2016-02-16,Aerie Pharmaceuticals To Present At The RBC Capital Markets 2016 Healthcare Conference
2016-02-15,JPMorgan, Deutsche Bank and Gilead Sciences: Doug Kass' Views
2016-02-15,General Motors, MetLife and Tesla: Doug Kass' Views
2016-02-02,Aerie Pharmaceuticals Enters Oversold Territory (AERI)
2016-01-11,Aerie Pharmaceuticals Becomes Oversold (AERI)
2015-12-28,Short Interest Moves 14.3% Lower For AERI
2015-12-01,Commit To Buy Aerie Pharmaceuticals At $17.50, Earn 20.7% Annualized Using Options
2015-11-05,Aerie Pharmaceuticals To Participate In Several Conferences In November
2015-11-04,Aerie Pharmaceuticals To Host Investor And Media Briefing During The 2015 American Academy Of Ophthalmology Annual Meeting On November 13, 2015
2015-11-03,Aerie Pharmaceuticals Reports Third Quarter 2015 Financial Results And Provides Business Update
2015-10-20,Aerie Pharmaceuticals To Announce Third Quarter 2015 Financial Results And Host Conference Call On Tuesday, November 3, 2015
2015-10-13,Short Interest Declines 23.2% For AERI
2015-09-24,Aerie Pharmaceuticals Initiates Fourth Phase 3 Clinical Trial Of RhopressaTM
2015-09-21,Aerie Pharmaceuticals Initiates First Phase 3 Registration Trial Of RoclatanTM
2015-09-16,Aerie Pharmaceuticals Reports Positive Rhopressa™ Phase 3 Efficacy Results
2015-09-09,Aerie Pharmaceuticals Announces That Richard A. Lewis, M.D., Has Joined As Chief Medical Officer
2015-09-08,Aerie Pharmaceuticals And Ramot At Tel Aviv University Enter Research Collaboration
2015-08-28,First Week of AERI October 16th Options Trading
2015-08-06,Aerie Pharmaceuticals is Now Oversold (AERI)
2015-08-06,Aerie Pharmaceuticals To Present At The Canaccord Genuity Growth Conference
2015-08-05,Aerie Pharmaceuticals Reports Second Quarter 2015 Financial Results And Provides Business Update
2015-08-05,Aerie Pharmaceuticals And GrayBug Announce Research Collaboration
2015-07-22,Aerie Pharmaceuticals To Announce Second Quarter 2015 Financial Results And Host Conference Call On Wednesday, August 5, 2015
2015-07-01,10 Worst Biotech Stocks in the NASDAQ
2015-07-01,Aerie Pharmaceuticals To Present At The Cantor Fitzgerald 2015 Healthcare Conference
2015-06-29,Commit To Buy Aerie Pharmaceuticals At $12.50, Earn 23% Annualized Using Options
2015-06-29,Aerie Pharmaceuticals Elects Julie McHugh And Michael M. Du Toit To The Company's Board Of Directors
2015-06-19,AERI INVESTOR DEADLINE ALERT: Law Offices Of Howard G. Smith Reminds Investors Of The Lead Plaintiff Deadline In The Class Action Lawsuit Against Aerie Pharmaceuticals, Inc.
2015-06-19,Aerie Pharmaceuticals (AERI) Stock Upgraded by Analysts
2015-06-19,Analysts' Actions -- BioMarin, BP, Micron and More
2015-06-19,Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!
2015-06-18,DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Aerie Pharmaceuticals, Inc. Of Upcoming Deadline
2015-06-16,Market News: Aerie Pharmaceuticals, Coty Inc, NCR Corporation
2015-06-16,Aerie (AERI) Stock Spikes After FDA Lowers Drug Trial's Primary Endpoint
2015-06-15,Aerie Pharmaceuticals Receives Positive Feedback From FDA
2015-06-12,5 Stocks Ready for Breakouts
2015-06-01,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Aerie Pharmaceuticals, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of June 29, 2015 - AERI
2015-05-27,Aerie Pharmaceuticals To Participate In Two Investor Conferences In June
2015-05-18,Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Against Aerie Pharmaceuticals, Inc. -- AERI
2015-05-15,EQUITY ALERT: The Rosen Law Firm Reminds Aerie Pharmaceuticals, Inc. Investors Of The Important Class Action Deadline
2015-05-11,INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Aerie Pharmaceuticals, Inc. (AERI) To Contact The Firm
2015-05-11,SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Aerie Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
2015-05-07,Aerie Pharmaceuticals Reports First Quarter 2015 Financial Results And Provides Business And Strategic Update
2015-05-07,AERIE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Against Aerie Pharmaceuticals, Inc. -- AERI
2015-05-07,Aerie Pharmaceuticals Elects Richard Croarkin To The Company's Board Of Directors
2015-05-06,SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc.
2015-05-04,4 Big-Volume Stocks to Trade for Breakouts
2015-05-03,Shades of 1990s in Social Media Earnings Misses: Best of Kass
2015-05-01,Robbins Arroyo LLP: Aerie Pharmaceuticals, Inc. (AERI) Misled Shareholders According To A Recently Filed Class Action
2015-04-30,EQUITY ALERT: The Rosen Law Firm Announces The Filing Of A Securities Class Action Against Aerie Pharmaceuticals, Inc.
2015-04-30,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors Of Class Action Against Aerie Pharmaceuticals, Inc. And Lead Plaintiff
2015-04-28,Lifshitz & Miller Law Firm Announces Investigation Of Aerie Pharmaceuticals, Inc., American Science And Engineering, Inc., Associated Estates Realty Corporation, Cadiz Inc., MagnaChip Semiconductor Corporation, Procera Networks, Inc. And Trinity Industries Inc.
2015-04-28,Aerie Pharmaceuticals To Announce First Quarter 2015 Financial Results And Host Conference Call On Thursday, May 7, 2015
2015-04-27,Harwood Feffer LLP Announces Investigation Of Aerie Pharmaceuticals, Inc.
2015-04-27,Aerie Pharmaceuticals (AERI) Stock Hits 52-Week Low on Rhopressa Trial Results
2015-04-27,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Aerie Pharmaceuticals, Inc.
2015-04-24,EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against Aerie Pharmaceuticals, Inc.
2015-04-24,Investor Alert: Investigation Of Aerie Pharmaceuticals, Inc. Announced By Holzer & Holzer, LLC
2015-04-24,Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Aerie Pharmaceuticals, Inc.
2015-04-23,Aerie Pharmaceuticals Reports Initial RhopressaTM Phase 3 Efficacy Results
2015-04-08,Aerie Pharmaceuticals To Present At The 14th Annual Needham Healthcare Conference
2015-03-31,First Week Of November 20th Options Trading For Aerie Pharmaceuticals (AERI)
2015-03-24,Aerie Pharmaceuticals Completes Enrollment In Second Phase 3 Registration Trial ("Rocket 2") Of Rhopressa™, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma
2015-03-03,Aerie Pharmaceuticals To Participate In Two Investor Conferences In March
2015-03-02,Aerie Pharmaceuticals Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Business And Product Development Update
2015-02-18,4 Stocks Breaking Out on Big Volume: Zillow, Aerie and More
2015-02-18,Aerie Pharmaceuticals Announces Potential Breakthroughs With New Preclinical Research
2015-02-17,Aerie Pharmaceuticals Announces Rhopressa™ Presentation At 2015 Meeting Of The Association For Ocular Pharmacology And Therapeutics
2015-02-17,Aerie Pharmaceuticals To Announce Fourth Quarter And Year End 2014 Financial Results And Host Conference Call On Monday, March 2, 2015
2015-02-03,Aerie Pharmaceuticals To Participate In Two Investor Conferences In February
2015-01-13,Commit To Buy Aerie Pharmaceuticals At $25, Earn 20.9% Annualized Using Options
2015-01-12,Aerie Pharmaceuticals Announces Acceleration Of Expected Timeline For Reporting Efficacy Results From Phase 3 Registration Trial ("Rocket 1") Of RhopressaTM
2014-12-16,Aerie Pharmaceuticals Added To NASDAQ Biotechnology Index (NBI)
2014-12-02,Aerie Pharmaceuticals Completes Enrollment In Phase 3 Registration Trial ("Rocket 1") Of Rhopressa™, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma
2014-11-24,Aerie Pharmaceuticals To Present At The Piper Jaffray 26th Annual Healthcare Conference
2014-11-12,Aerie Pharmaceuticals To Present At The 2014 Stifel Nicolaus Annual Healthcare Conference
2014-11-11,Aerie Pharmaceuticals Reports Third Quarter 2014 Financial Results And Provides Business And Product Development Update
2014-10-28,Aerie Pharmaceuticals To Announce Third Quarter 2014 Financial Results And Host Conference Call On Tuesday, November 11, 2014
2014-10-06,Aerie Pharmaceuticals Elects Benjamin F. McGraw, III To Its Board Of Directors
2014-09-30,Aerie Announces Closing Of $125 Million Convertible Notes Financing
2014-09-09,Aerie Announces $125 Million Convertible Notes
2014-09-04,Aerie Pharmaceuticals To Host Investor Day On September 10, 2014
2014-09-03,Aerie Pharmaceuticals Inc. Initiates Phase 3 Safety-Only Registration Trial In Canada Of RhopressaTM In Patients With Glaucoma
2014-08-07,Aerie Pharmaceuticals To Present At The Canaccord Genuity 34th Annual Growth Conference
2014-08-06,Aerie Pharmaceuticals Reports Second Quarter 2014 Financial Results And Provides Business And Product Development Update
2014-07-24,Aerie Pharmaceuticals, Inc. Receives Health Canada &#8220;No Objection Letter&#8221; To Commence Phase 3 Registration Trial Of RhopressaTM In Patients With Glaucoma In Canada
2014-07-23,Aerie Pharmaceuticals To Announce Second Quarter 2014 Financial Results And Host Conference Call On Wednesday, August 6, 2014
2014-07-14,Aerie Pharmaceuticals Initiates Phase 3 Registration Trials Of RhopressaTM, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma
2014-07-07,Aerie Pharmaceuticals Expands Management Team, Names Michael McCleerey As Vice President, Marketing
2014-06-25,Why Aerie Pharmaceuticals (AERI) Stock Is Soaring Today
2014-06-09,3 Big-Volume Stocks to Trade for Breakouts
2017-03-07,Aerie Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Business Update
2017-03-05,4 Small-Cap Biotech Stars
2017-03-03,4 Small-Cap Biotech Stars
2017-03-02,Aerie Pharmaceuticals To Present At Three Investor Conferences In March
2017-03-01,Aerie Pharmaceuticals Announces Resubmission Of NDA For RhopressaTM (netarsudil Ophthalmic Solution) 0.02%
2017-02-27,Aerie Pharmaceuticals To Announce Fourth Quarter And Year End 2016 Financial Results And Host Conference Call On Tuesday, March 7, 2017
2017-02-15,Aerie Pharmaceuticals To Present At The RBC Capital Markets 2017 Global Healthcare Conference
2017-02-13,Noteworthy Monday Option Activity: AERI, NHTC, SUPN
2017-02-06,Aerie Pharmaceuticals Announces Appointment Of Huan Sheng, M.D., Ph.D., As Director Clinical Research And Drug Safety
2017-02-03,Aerie Pharmaceuticals Announces Appointment Of Barry Ivin As Site Director Of New Manufacturing Plant In Ireland
2017-01-27,Dearth of Momentum Helps Build 'Wall of Worry'
2017-01-23,Aerie Pharmaceuticals Announces Appointment Of Kristine Erickson, O.D., Ph.D., As Vice President Clinical Research
2017-01-23,Allergan, Apple, Facebook: Doug Kass' Views
2017-01-16,Allergan, Citigroup, Apple: Doug Kass' Views
2017-01-09,Aerie Pharmaceuticals Enters Into Lease Agreement For New Manufacturing Plant In Ireland
2017-01-03,Inotek Pharma Shares Plummet Following Negative Glaucoma Trial Results
2017-01-03,Inotek Pharma Glaucoma Drug Suffers Study Setback at Start of New Year
2016-12-23,Aerie Pharmaceuticals Provides Update On Timing Of NDA Filing For RhopressaTM (netarsudil Ophthalmic Solution) 0.02%
2016-12-22,What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
2016-12-19,Aerie Pharmaceuticals Announces Appointment Of Judith J. Robertson As Chief Commercial Officer
2016-12-19,Apple, Alphabet, Starbucks: Doug Kass' Views
2016-12-07,Aerie Pharmaceuticals Completes Enrollment Of Mercury 2 Phase 3 Registration Trial Of Roclatan™ (netarsudil/latanoprost Ophthalmic Solution) 0.02%/0.005%
2016-12-01,Aerie Pharmaceuticals To Participate In Two Investor Conferences In December
2016-11-28,Home Depot, Lowe's, Best Buy: Doug Kass' Views
2016-11-25,Apple Continues to Underperform; the Market Is Resistant: Best of Kass
2016-11-21,Facebook, Home Depot, Disney: Doug Kass' Views
2016-11-16,4 Stocks You Should Watch Because They're Breaking Out Higher
2016-11-07,Cisco, Allergan, Facebook: Doug Kass' Views
2016-11-03,Aerie Pharmaceuticals To Participate In Three Investor Conferences In November
2016-11-02,Aerie Pharmaceuticals Reports Third Quarter 2016 Financial Results And Provides Business Update
2016-10-27,Aerie Pharmaceuticals Reports Positive Topline Efficacy Results Of Rocket 4 Phase 3 Trial Of RhopressaTM (netarsudil Ophthalmic Solution) 0.02%
2016-10-25,Aerie Pharmaceuticals To Announce Third Quarter 2016 Financial Results And Host Conference Call On Wednesday, November 2, 2016
2016-10-24,Schlumberger, Amazon, Apple: Doug Kass' Views
2016-10-03,J.C.Penney, Wells Fargo, Deutsche Bank: Doug Kass' Views
2016-09-28,Aerie Pharmaceuticals To Host Investor Day On October 5, 2016
2016-09-21,Cloudy Outlook for Aerie Pharma's Glaucoma Drug
2016-09-19,Wells Fargo, Citigroup, Apple: Doug Kass' Views
2016-09-16,Notable Friday Option Activity: AERI, AWH, WATT
2016-09-16,Aerie Pharmaceuticals Raises $125 Million In Public Offerings
2016-09-15,Aerie Pharmaceuticals Announces Public Offering Of Common Stock
2016-09-15,Trending Tickers: AAPL, TMUS, FIT, AERI
2016-09-15,Bought Aerie Earlier? Congratulations
2016-09-15,Why Shares of Aerie Pharmaceuticals (AERI) are Soaring Today
2016-09-14,Aerie Pharmaceuticals Reports Positive Roclatan™ (netarsudil/latanoprost Ophthalmic Solution) 0.02%/0.005% Phase 3 Topline Efficacy Results
2016-09-14,Fear of Being Left Out Is Lifting Indices
2016-09-09,4 Biotechs Set to Provide a Shot in the Arm
2016-09-09,4 Biotechs Set to Provide a Shot in the Arm
2016-09-06,Aerie Pharmaceuticals Submits New Drug Application To U.S. Food And Drug Administration For Rhopressa™ (netarsudil Ophthalmic Solution) 0.02%
2016-08-30,2 Biotechs to Watch Ahead of the Election
2016-08-25,Aerie Pharmaceuticals Stock Sees Short Interest Decline 17%
2016-08-04,Aerie Pharmaceuticals To Present At The Canaccord Genuity Growth Conference
2016-08-03,Aerie Pharmaceuticals Reports Second Quarter 2016 Financial Results And Provides Business Update
2016-07-27,Aerie Pharmaceuticals To Announce Second Quarter 2016 Financial Results And Host Conference Call On Wednesday, August 3, 2016
2016-07-22,Noteworthy Friday Option Activity: AERI, NAV, CBI
2016-07-06,Aerie Pharmaceuticals To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
2016-06-27,First Week of February 2017 Options Trading For Aerie Pharmaceuticals (AERI)
2016-06-16,Aerie Pharmaceuticals Completes Enrollment Of Rocket 4 Phase 3 Clinical Trial Of RhopressaTM (netarsudil Ophthalmic Solution) 0.02%
2016-06-02,Aerie Pharmaceuticals To Participate In Two Investor Conferences In June
2016-05-05,Aerie Pharmaceuticals Completes Enrollment Of Mercury 1 Phase 3 Registration Trial Of RoclatanTM (netarsudil/latanoprost Ophthalmic Solution) 0.02%/0.005%
2016-05-04,Aerie Pharmaceuticals To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference
2016-05-02,Aerie Pharmaceuticals Reports First Quarter 2016 Financial Results And Provides Business Update
2016-04-25,Aerie Pharmaceuticals To Announce First Quarter 2016 Financial Results And Host Conference Call On Monday, May 2, 2016
2016-04-14,Commit To Buy Aerie Pharmaceuticals At $12.50, Earn 38.6% Annualized Using Options
2016-04-05,Aerie Pharmaceuticals To Present At The 15th Annual Needham Healthcare Conference
2016-03-28,Short Interest Moves 18.4% Higher For AERI
2016-03-28,Aerie Pharmaceuticals Initiates Second Phase 3 Registration Trial Of RoclatanTM (netarsudil/latanoprost Ophthalmic Solution) 0.02%/0.005%
2016-03-17,Aerie Pharmaceuticals Reports Update On Positive Safety Results For RhopressaTM QD (netarsudil Ophthalmic Solution) 0.02%
2016-03-09,Aerie Pharmaceuticals Becomes Oversold (AERI)
2016-03-07,Tesla, Amazon and Netflix: Doug Kass' Views
2016-03-03,Noteworthy Thursday Option Activity: AERI, GB, W
2016-03-03,Aerie Pharma Falls on Glaucoma Eye Drop Safety Concerns
2016-03-03,Aerie Pharmaceuticals Announces Availability On Its Website Of Abstracts To Be Presented At The American Glaucoma Society 26th Annual Meeting
2016-03-01,Aerie Pharmaceuticals Reports Year End 2015 Financial Results And Provides Business Update
2016-02-22,Aerie Pharmaceuticals Announces Four New Abstracts To Be Presented At The American Glaucoma Society 26th Annual Meeting Next Week
2016-02-22,Aerie Pharmaceuticals To Announce Fourth Quarter And Year End 2015 Financial Results And Host Conference Call On Tuesday, March 1, 2016
2016-02-22,Amazon, Berkshire Hathaway and Potash: Doug Kass' Views
2016-02-19,What Carl Icahn Is Doing; Biotech Breakout: Best of Kass
2016-02-18,One Reason Why Aerie Pharmaceuticals (AERI) Stock is Soaring Today
2016-02-17,Aerie Pharmaceuticals Reports Positive RhopressaTM QD (netarsudil Ophthalmic Solution) 0.02% 12 Month Interim Safety Results For Rocket 2
2016-02-16,Aerie Pharmaceuticals To Present At The RBC Capital Markets 2016 Healthcare Conference
2016-02-15,JPMorgan, Deutsche Bank and Gilead Sciences: Doug Kass' Views
2016-02-15,General Motors, MetLife and Tesla: Doug Kass' Views
2016-02-02,Aerie Pharmaceuticals Enters Oversold Territory (AERI)
2016-01-11,Aerie Pharmaceuticals Becomes Oversold (AERI)
2015-12-28,Short Interest Moves 14.3% Lower For AERI
2015-12-01,Commit To Buy Aerie Pharmaceuticals At $17.50, Earn 20.7% Annualized Using Options
2015-11-05,Aerie Pharmaceuticals To Participate In Several Conferences In November
2015-11-04,Aerie Pharmaceuticals To Host Investor And Media Briefing During The 2015 American Academy Of Ophthalmology Annual Meeting On November 13, 2015
2015-11-03,Aerie Pharmaceuticals Reports Third Quarter 2015 Financial Results And Provides Business Update
2015-10-20,Aerie Pharmaceuticals To Announce Third Quarter 2015 Financial Results And Host Conference Call On Tuesday, November 3, 2015
2015-10-13,Short Interest Declines 23.2% For AERI
2015-09-24,Aerie Pharmaceuticals Initiates Fourth Phase 3 Clinical Trial Of RhopressaTM
2015-09-21,Aerie Pharmaceuticals Initiates First Phase 3 Registration Trial Of RoclatanTM
2015-09-16,Aerie Pharmaceuticals Reports Positive Rhopressa™ Phase 3 Efficacy Results
2015-09-09,Aerie Pharmaceuticals Announces That Richard A. Lewis, M.D., Has Joined As Chief Medical Officer
2015-09-08,Aerie Pharmaceuticals And Ramot At Tel Aviv University Enter Research Collaboration
2015-08-28,First Week of AERI October 16th Options Trading
2015-08-06,Aerie Pharmaceuticals is Now Oversold (AERI)
2015-08-06,Aerie Pharmaceuticals To Present At The Canaccord Genuity Growth Conference
2015-08-05,Aerie Pharmaceuticals Reports Second Quarter 2015 Financial Results And Provides Business Update
2015-08-05,Aerie Pharmaceuticals And GrayBug Announce Research Collaboration
2015-07-22,Aerie Pharmaceuticals To Announce Second Quarter 2015 Financial Results And Host Conference Call On Wednesday, August 5, 2015
2015-07-01,10 Worst Biotech Stocks in the NASDAQ
2015-07-01,Aerie Pharmaceuticals To Present At The Cantor Fitzgerald 2015 Healthcare Conference
2015-06-29,Commit To Buy Aerie Pharmaceuticals At $12.50, Earn 23% Annualized Using Options
2015-06-29,Aerie Pharmaceuticals Elects Julie McHugh And Michael M. Du Toit To The Company's Board Of Directors
2015-06-19,AERI INVESTOR DEADLINE ALERT: Law Offices Of Howard G. Smith Reminds Investors Of The Lead Plaintiff Deadline In The Class Action Lawsuit Against Aerie Pharmaceuticals, Inc.
2015-06-19,Aerie Pharmaceuticals (AERI) Stock Upgraded by Analysts
2015-06-19,Analysts' Actions -- BioMarin, BP, Micron and More
2015-06-19,Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!
2015-06-18,DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Aerie Pharmaceuticals, Inc. Of Upcoming Deadline
2015-06-16,Market News: Aerie Pharmaceuticals, Coty Inc, NCR Corporation
2015-06-16,Aerie (AERI) Stock Spikes After FDA Lowers Drug Trial's Primary Endpoint
2015-06-15,Aerie Pharmaceuticals Receives Positive Feedback From FDA
2015-06-12,5 Stocks Ready for Breakouts
2015-06-01,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Aerie Pharmaceuticals, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of June 29, 2015 - AERI
2015-05-27,Aerie Pharmaceuticals To Participate In Two Investor Conferences In June
2015-05-18,Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Against Aerie Pharmaceuticals, Inc. -- AERI
2015-05-15,EQUITY ALERT: The Rosen Law Firm Reminds Aerie Pharmaceuticals, Inc. Investors Of The Important Class Action Deadline
2015-05-11,INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Aerie Pharmaceuticals, Inc. (AERI) To Contact The Firm
2015-05-11,SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Aerie Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
2015-05-07,Aerie Pharmaceuticals Reports First Quarter 2015 Financial Results And Provides Business And Strategic Update
2015-05-07,AERIE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Against Aerie Pharmaceuticals, Inc. -- AERI
2015-05-07,Aerie Pharmaceuticals Elects Richard Croarkin To The Company's Board Of Directors
2015-05-06,SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc.
2015-05-04,4 Big-Volume Stocks to Trade for Breakouts
2015-05-03,Shades of 1990s in Social Media Earnings Misses: Best of Kass
2015-05-01,Robbins Arroyo LLP: Aerie Pharmaceuticals, Inc. (AERI) Misled Shareholders According To A Recently Filed Class Action
2015-04-30,EQUITY ALERT: The Rosen Law Firm Announces The Filing Of A Securities Class Action Against Aerie Pharmaceuticals, Inc.
2015-04-30,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors Of Class Action Against Aerie Pharmaceuticals, Inc. And Lead Plaintiff
2015-04-28,Lifshitz & Miller Law Firm Announces Investigation Of Aerie Pharmaceuticals, Inc., American Science And Engineering, Inc., Associated Estates Realty Corporation, Cadiz Inc., MagnaChip Semiconductor Corporation, Procera Networks, Inc. And Trinity Industries Inc.
2015-04-28,Aerie Pharmaceuticals To Announce First Quarter 2015 Financial Results And Host Conference Call On Thursday, May 7, 2015
2015-04-27,Harwood Feffer LLP Announces Investigation Of Aerie Pharmaceuticals, Inc.
2015-04-27,Aerie Pharmaceuticals (AERI) Stock Hits 52-Week Low on Rhopressa Trial Results
2015-04-27,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Aerie Pharmaceuticals, Inc.
2015-04-24,EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against Aerie Pharmaceuticals, Inc.
2015-04-24,Investor Alert: Investigation Of Aerie Pharmaceuticals, Inc. Announced By Holzer & Holzer, LLC
2015-04-24,Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Aerie Pharmaceuticals, Inc.
2015-04-23,Aerie Pharmaceuticals Reports Initial RhopressaTM Phase 3 Efficacy Results
2015-04-08,Aerie Pharmaceuticals To Present At The 14th Annual Needham Healthcare Conference
2015-03-31,First Week Of November 20th Options Trading For Aerie Pharmaceuticals (AERI)
2015-03-24,Aerie Pharmaceuticals Completes Enrollment In Second Phase 3 Registration Trial ("Rocket 2") Of Rhopressa™, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma
2015-03-03,Aerie Pharmaceuticals To Participate In Two Investor Conferences In March
2015-03-02,Aerie Pharmaceuticals Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Business And Product Development Update
2015-02-18,4 Stocks Breaking Out on Big Volume: Zillow, Aerie and More
2015-02-18,Aerie Pharmaceuticals Announces Potential Breakthroughs With New Preclinical Research
2015-02-17,Aerie Pharmaceuticals Announces Rhopressa™ Presentation At 2015 Meeting Of The Association For Ocular Pharmacology And Therapeutics
2015-02-17,Aerie Pharmaceuticals To Announce Fourth Quarter And Year End 2014 Financial Results And Host Conference Call On Monday, March 2, 2015
2015-02-03,Aerie Pharmaceuticals To Participate In Two Investor Conferences In February
2015-01-13,Commit To Buy Aerie Pharmaceuticals At $25, Earn 20.9% Annualized Using Options
2015-01-12,Aerie Pharmaceuticals Announces Acceleration Of Expected Timeline For Reporting Efficacy Results From Phase 3 Registration Trial ("Rocket 1") Of RhopressaTM
2014-12-16,Aerie Pharmaceuticals Added To NASDAQ Biotechnology Index (NBI)
2014-12-02,Aerie Pharmaceuticals Completes Enrollment In Phase 3 Registration Trial ("Rocket 1") Of Rhopressa™, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma
2014-11-24,Aerie Pharmaceuticals To Present At The Piper Jaffray 26th Annual Healthcare Conference
2014-11-12,Aerie Pharmaceuticals To Present At The 2014 Stifel Nicolaus Annual Healthcare Conference
2014-11-11,Aerie Pharmaceuticals Reports Third Quarter 2014 Financial Results And Provides Business And Product Development Update
2014-10-28,Aerie Pharmaceuticals To Announce Third Quarter 2014 Financial Results And Host Conference Call On Tuesday, November 11, 2014
2014-10-06,Aerie Pharmaceuticals Elects Benjamin F. McGraw, III To Its Board Of Directors
2014-09-30,Aerie Announces Closing Of $125 Million Convertible Notes Financing
2014-09-09,Aerie Announces $125 Million Convertible Notes
2014-09-04,Aerie Pharmaceuticals To Host Investor Day On September 10, 2014
2014-09-03,Aerie Pharmaceuticals Inc. Initiates Phase 3 Safety-Only Registration Trial In Canada Of RhopressaTM In Patients With Glaucoma
2014-08-07,Aerie Pharmaceuticals To Present At The Canaccord Genuity 34th Annual Growth Conference
2014-08-06,Aerie Pharmaceuticals Reports Second Quarter 2014 Financial Results And Provides Business And Product Development Update
2014-07-24,Aerie Pharmaceuticals, Inc. Receives Health Canada &#8220;No Objection Letter&#8221; To Commence Phase 3 Registration Trial Of RhopressaTM In Patients With Glaucoma In Canada
2014-07-23,Aerie Pharmaceuticals To Announce Second Quarter 2014 Financial Results And Host Conference Call On Wednesday, August 6, 2014
2014-07-14,Aerie Pharmaceuticals Initiates Phase 3 Registration Trials Of RhopressaTM, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma
2014-07-07,Aerie Pharmaceuticals Expands Management Team, Names Michael McCleerey As Vice President, Marketing
2014-06-25,Why Aerie Pharmaceuticals (AERI) Stock Is Soaring Today
2014-06-09,3 Big-Volume Stocks to Trade for Breakouts
